Articles Tagged With: HIV
-
Infectious Disease Updates
Visceral Larva Migrans from Baylisascariasis; Measles Testing of Persons with HIV; Ambulatory Glucose Monitoring a Risk for Bloodborne Pathogens
-
Lenacapavir Injection and Tablets (Yeztugo)
The U.S. Food and Drug Administration has approved lenacapavir, a potent, first-in-class, capsid inhibitor, for reducing the risk of sexually acquired human immunodeficiency virus type 1.
-
Twice-Yearly Subcutaneous Lenacapavir Injection Prevents HIV Infection
Subcutaneous injection of lenacapavir every 26 weeks had 100% efficacy in preventing human immunodeficiency virus (HIV) infection in a high-risk population.
-
A Review of HIV Pre-Exposure Prophylaxis
Human immunodeficiency virus (HIV) pre-exposure prophylaxis is a tool for preventing HIV, especially among high-risk populations. Three medication options are available. Regular screening for HIV and sexually transmitted infections is required, and adherence is crucial for effectiveness. PrEP is underused but increasingly covered by insurance, offering an important preventive option in sexual healthcare.
-
Twice-Yearly Subcutaneous Lenacapavir Injection Prevents HIV Infection
Subcutaneous injection of lenacapavir every 26 weeks had 100% efficacy in preventing human immunodeficiency virus (HIV) infection in a high-risk population.
-
Message Needs to Get Out that PrEP Is Not Only for Cisgender Men
Cisgender women sometimes are left out of the provider-patient conversations when it comes to discussing their risk of human immunodeficiency virus (HIV) infection and how pre-exposure prophylaxis (PrEP) can make them safer, a new paper finds.
-
A Review of HIV Pre-Exposure Prophylaxis
Knowing one’s human immunodeficiency virus (HIV) status can help patients take steps to prevent transmission. Male and female condoms are options for preventing HIV during sexual intercourse. These products are widely available over the counter in retail stores and pharmacies and their use should be encouraged for preventing sexually transmitted infections. Yet, there is another option available, pre-exposure prophylaxis (PrEP), for patients to prevent HIV that many providers have not yet added to their armamentarium. This special feature will review the indications for PrEP, its use, and the medications recommended.
-
‘Vampire’ Facials and HIV Transmission
Evidence indicates that human immunodeficiency virus was transmitted in association with microneedling of facial lesions with platelet-rich plasma.
-
An Old Pro Stays in the Fight Against Needlesticks
At age 78, with more than 50 years of clinical consultation and research on needlesticks, sharps injuries, and medical waste, Terry Grimmond, FASM, BAgrSc, GrDpAdEdTr, says he retired at the end of 2023 but is still winding his career down with a few final projects.
-
PEP Clock Ticking After Sharps Injury
Infection preventionists involved in post-exposure prophylaxis (PEP) for potential human immunodeficiency virus needlesticks should know the clock is ticking after injury follow-up begins. Such needlesticks certainly are a rare event, but the risk of seroconversion is not zero. A call to the National Clinician Consultation Center PEP line could be in order.